J Korean Med Assoc.  2003 Jul;46(7):620-628.

Recent Advances in the Diagnosis and Treatment for Rectal Cancer

• Kim NK

Abstract

Optimal surgical treatment of rectal cancer is important to control local disease and preserve voiding and sexual function with a good quality of life. Anal sphincter preservation is a challenging issue in distal rectal cancer. Preoperative combined multimodality treatment might increase the rate of anal sphincter preservation. Postoperative adjuvant therapy with chemoradiation in stage II and III seems to increase survical rates and decrease local failure. To achieve the best oncologic and functional outcomes, the extent and type of surgery must be chosen based upon accurate preoperative staging of rectal cancer. Early cancer can be managed with minimal invasive surgery, however, neoadjuvant chemoradiation therapy on patients with locally advanced rectal cancer can improve resectability and oncologic outcomes. The rate of local failure is markedly decreased with the development of sharp pelvic dissection and the concept of total mesorectal excision. Total mesorectal excision is to remove rectal cancer and surrounding mesorectum completely without interruption of the rectal proper fascia. Optimized surgical technique and adjuvant chemoradiation can guarantee a promising oncologic outcomes ; however, difficulties of management of patients with local or systemic failure still remain.

Keyword

Rectal Cancer; Optimal surgical treatment; Multimodality treatment

MeSH Terms

Anal Canal
Diagnosis*
Fascia
Humans
Quality of Life
Rectal Neoplasms*

Figure

• 

  Figure 1

• 

  Figure 2

• 

  Figure 3

• 

  Figure 4

Reference

1. Kim NK, Choi JS, Sohn SK, Min JS. Transrectal ultrasonography in preoperative staging of rectal cancer. Yonsei Med J. 1994. 35:396–403.

3. Kim NK, Kim MJ, Park JK, Park SI, Min JS. Preoperative staging of rectal cancer with MRI : accuracy and clinical usefulness. Ann Surg Oncol. 2000. 7:732–737.

4. Kim NK, Kim MJ, SH Yun, Sohn SK, Min JS. Comparative study of transrectal ultrasonography, pelvic computerized tomography and magnetic resonance imaging in preoperative staging of rectal cancer. Dis Colon Rectum. 1999. 42:770–775.

5. Moriya Y, Hojo K, Sawada T, Koyama Y. Significance of lateral node dissection for advanced rectal cancer at or below the peritoneal reflection. Dis Colon Rectum. 1989. 32:307–315.

6. Moriya Y, Sugihara K, Akasu T, Fujita S. Importance of extended lymphadenectomy with lateral node dissection for advanced lower rectal cancer. World J Surg. 1997. 21:728–732.

7. Heald RJ, Morgan BJ, Ryall RD, Sexton R, MacFarlane JK. Rectal Cancer : The Basingstoke experience of total mesorectal excision 1978-1997. Arch Surg. 1998. 133:894–899.

8. Enker WE. Total Mesorectal Excision-the New Golden standard of surgery for rectal cancer. Ann Med. 1997. 29:127–133.

9. Enker WE, Thaler HT, Cranor ML, Polyak T. Total Mesorectal Excision in the operative treatment of carcinoma of the rectum. J Am Coll Surg. 1995. 181:335–346.

11. Lee W, Lee D, Choi S, Chun H. Transanal endoscopic microsurgery and radical surgery : T1 and T2 rectal cancer. Surg Endosc. 2003. 17:1283–1287.

12. Wong WD, Congliosi SM, Spencer MP, Corman ML, Tan P, Tsai JY. The safety and efficacy of the artificial bowel sphincter for fecal incontinence : results from a multicenter cohort study. Dis Colon Rectum. 2002. 45:1139–1153.

14. Kim NK, Lim DJ, Yun SH, Sohn SK, Min JS. Ultralow anterior resection and coloanal anastomosis for distal rectal cancer: fucntional and oncologic outcomes. Int J Colorectal Dis. 2001. 16:234–237.

15. Kim NK, Ahn TW, Park JK, Lee KY, Lee WH, Min JS, et al. Assessment of sexual and voiding function after total mesorectal excision with pelvic autonomic nerve preservation in male with rectal cancer. Dis Colon Rectum. 2002. 45:1178–1185.

16. Havenga K, Enker WE, Norstein J, Moriya Y, Heald RJ, van de Velde CJ, et al. Improved survival and local control after total mesorectal excision or D3 lymphadenectomy in the treatment of primary rectal cancer : an international analysis of 1411 patients. Eur J Surg Oncol. 1999. 25:368–374.

23. Kim NK, Min JS, Park JK, Yun SH, Seong JS, Roh JK, et al. Intravenous 5 fluorouracil versus oral doxifluridine as preoperative concurrent chemoradiation for locally advanced rectal cancer. Jpn J Clin Oncol. 2001. 31:25–29.

25. Minsky BD. Adjvuant therapy of resectable rectal cancer. Cancer treatment reviews. 2002. 28:181–188.